NITI Aayog Panel to Drive AIIMS Modernization

NITI Aayog, the Indian government’s premier think tank, has established a committee to devise a roadmap for transforming AIIMS, New Delhi, into a world-class institution for medical research and healthcare excellence. Led by NITI Aayog member VK Paul, the committee will analyze current systems and propose reforms with specific timelines for their implementation. This initiative is part of a broader effort to enhance healthcare infrastructure, governance, and self-sufficiency in AIIMS.

Additionally, NITI Aayog has been working on Universal Health Coverage (UHC) and rare disease treatment affordability, partnering with CSEP Research Foundation to examine global UHC models. It has also facilitated the indigenous production of affordable drugs for rare diseases, significantly reducing treatment costs.

Key Highlights of AIIMS Transformation Panel

Committee Formation

  • Led by VK Paul, focusing on AIIMS New Delhi’s transformation.

Objectives

  • Assess current systems & propose reforms with clear timelines.
  • Improve patient inflow management and hospital governance.
  • Develop Key Performance Indicators (KPIs) for clinical, academic, and research excellence.
  • Enhance financial prudence & sustainability in AIIMS operations.

Focus Areas

  • Governance & transparency.
  • Research excellence.
  • Clinical & academic improvements.
  • Self-sufficiency & financial sustainability.

NITI Aayog’s Efforts on Universal Health Coverage (UHC)

  • Partnership with CSEP Research Foundation to study global UHC models.

Draft paper on healthcare financing strategies,

  • Addresses supply-side & demand-side financing.
  • Aims to improve healthcare accessibility, quality, and affordability.
  • Extensive government & stakeholder consultations planned to shape policies.

Rare Disease Drug Accessibility Initiative

  • Effort to provide affordable indigenous treatments for rare diseases.
  • 4 affordable drugs introduced, priced at 1/60th to 1/100th of imported versions.
  • 4 more drugs undergoing regulatory approval, expected to launch by year-end.
Summary/Static Details
Why in the news? NITI Aayog Panel to Drive AIIMS Modernization
AIIMS Transformation Panel Committee led by VK Paul to improve AIIMS systems, governance, and sustainability.
Key Focus Areas Patient inflow, KPIs, governance, financial sustainability, transparency.
Universal Health Coverage (UHC) Study NITI Aayog & CSEP Research Foundation examining global UHC models.
Healthcare Financing Reforms Addresses supply & demand-side financing to improve accessibility & affordability.
Affordable Rare Disease Drugs 4 drugs introduced at 1/60th to 1/100th of imported costs, 4 more in pipeline.
Shivam

Recent Posts

Which District has the Longest Name in Uttarakhand?

Uttarakhand is a beautiful state in northern India, known for its scenic mountains, rivers and…

15 hours ago

GA Questions on Nationalisation of 14 Banks in 1969

The nationalisation of 14 banks in 1969 was a very important event in India's banking…

17 hours ago

List of Countries Starting with the Letter ‘I,’ Know About Them

There are many countries in the world and each one has a name that makes…

18 hours ago

International Moon Day 2025 – History, Significance, Objectives & UN Role

International Moon Day, celebrated every year on July 20, commemorates the historic first human landing…

19 hours ago

Which Indian City is Known as City of Kidney Beans?

India is a country with many cities and each one is known for something special.…

19 hours ago

World Chess Day 2025 – History, Significance & Key Insights

World Chess Day is celebrated globally on July 20 every year to commemorate the founding…

19 hours ago